ApprovalTrail

Approval · Notice of Compliance 19495 · 2017

TECFIDERA: Notice of Compliance 19495

Issued July 6, 2017

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
19495
Date
July 6, 2017
Company
Biogen Canada IncToronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Updates to the product monograph

Products in this notice

BrandDINStatus today
TECFIDERANot yet assigned—

Medicinal ingredients